Options and prospects for drug treatment of uterine fibroids
https://doi.org/10.21518/2079-701X-2013-3-106-109
Abstract
The emergence of new techniques and methods that inhibit tumor growth and promote regression of symptoms is introducing new approaches to the management and care of patients with uterine fibroids, both in surgical and drug treatment.
About the Authors
T. E. Samoylova
the Kazakh National Medical University named after S.D. Asfendiyarov, Almaty
Russian Federation
Russian Federation
D. Zh. Maksutova
the Kazakh National Medical University named after S.D. Asfendiyarov, Almaty
Russian Federation
Russian Federation
References
1. Cook J.D. Treatment strategies for uterine leiomyoma: the role of hormonal modulation / J.D. Cook, C.L. Walker // Reprod. Med. - 2004. - Vol. 22. - №2.
2. Di Lieto A. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas / A. Di Lieto, M. De Falco, F. Pollio et al. // J. Soc. Gynecol. Investig. - 2005. - Vol. 12 (2). - P. 123-128.
3. Eisinger S.H. Low-dose mifepristone for uterine leiomyomata / S.H. Eisinger, S Meldrum, K. Fiscella et al. // Obstet. Gynecol. - 2003. - Vol. 101. - P. 243-250.
4. Healy D.L. Uterine fibroids / D.L. Healy B. Vollenhoven, G. Weston // In: Shaw R.W., Soutter W.P., Stanton S.L., eds. Gynecology. 3rd ed. - Philadelphia: Churchill Livingstone, 2003. - P. 479-494.
5. Hyder S.M. Regulation of VEGF in the reproductive tract by sex-steroid hormones / S.M. Hyder, G.M. Stancel // Histol. Histopathol. - 2000. - Vol. 15. - P. 325-334.
6. Luo X. Leiomyoma and myometrial gene expression profiles and T response to gonadotropin releasing hormone analogue (GnRHa) therapy / X. Luo, L Ding, J. Xu et al. // Endocrinology. - 2004. - Vol. 16.
7. Ratherford A.J. Molecular pharmacology // In: Reproductive Medicine. Molecular, Cellular and Genetic Fundamentals / Ed. O.J. Bart, M. Fauser. - 2003. - P. 313-362.
8. Steinauer J. Systematic review of Mifepristone for the treatment of uterine leiomyomata / J. Steinauer, E. Pritts, R. Jackson et al. // J. Obstet. Gynecol. - 2004. - Vol. 103. - №6. - P. 1331-1336.
9. Zeng C., Gu M., Huang H. A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone. Zhonghua Fu Chan Ke Za Zhi. 1998 Aug; №33 (8): P. 490-2.
Review
For citations:
Samoylova TE, Maksutova DZ. Options and prospects for drug treatment of uterine fibroids. Meditsinskiy sovet = Medical Council. 2013;(3):106-109. (In Russ.) https://doi.org/10.21518/2079-701X-2013-3-106-109
Views:
308
Email this article 